These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19782487)

  • 1. [Evaluation of an education program for patients taking oral anticoagulants: Experience of the GRANTED network in Isère].
    Blaise S; Satger B; Fontaine M; Yver J; Rastel D; Toffin L; Seinturier C; Ramos M; Bosson JL; Pernod G;
    J Mal Vasc; 2009 Nov; 34(5):346-53. PubMed ID: 19782487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
    Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic.
    Cortelazzo S; Finazzi G; Viero P; Galli M; Remuzzi A; Parenzan L; Barbui T
    Thromb Haemost; 1993 Apr; 69(4):316-20. PubMed ID: 8497842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial.
    Siebenhofer A; Rakovac I; Kleespies C; Piso B; Didjurgeit U
    Thromb Haemost; 2007 Mar; 97(3):408-16. PubMed ID: 17334508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of self-management of oral anticoagulation in patients with atrial fibrillation or deep vein thrombosis.
    Heidinger KS; Bernardo A; Taborski U; Müller-Berghaus G
    Thromb Res; 2000 May; 98(4):287-93. PubMed ID: 10822075
    [No Abstract]   [Full Text] [Related]  

  • 7. [Which factors are associated to hemorrhagic adverse drug events related to antivitamin K?].
    Al Hajje AH; Calop N; Bosson JL; Calop J; Allenet B
    Ann Pharm Fr; 2010 Jan; 68(1):36-43. PubMed ID: 20176161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient education and oral anticoagulant therapy.
    Barcellona D; Contu P; Marongiu F
    Haematologica; 2002 Oct; 87(10):1081-6. PubMed ID: 12368164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality evaluation of the management of oral anticoagulation therapy (OAT): the awareness of treating physicians and the education of patients needs to be improved.
    Gras-Champel V; Voyer A; Guillaume N; Lematte C; Roussel B; Machu-Prestaux C; Andréjak M; Lefrère JJ
    Am J Ther; 2006; 13(3):223-8. PubMed ID: 16772764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
    Phillips KW; Ansell J
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of oral anticoagulation in patients with atrial fibrillation: a cross-sectional study in general practice.
    Neree C
    Eur J Gen Pract; 2006; 12(4):163-8. PubMed ID: 17127602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ambulatory follow-up in oral anticoagulation: recommendations for clinical practice].
    Christen Y; Perrier A; de Moerloose P
    Schweiz Med Wochenschr; 1996 Mar; 126(12):471-6. PubMed ID: 8650511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism.
    Torn M; van der Meer FJ; Rosendaal FR
    Arch Intern Med; 2004 Mar; 164(6):668-73. PubMed ID: 15037497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oral anticoagulation in patients with cancer.
    Bona RD; Hickey AD; Wallace DM
    Thromb Haemost; 1997 Jul; 78(1):137-40. PubMed ID: 9198143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the implications of oral anticoagulation therapy.
    Gallagher D; Rix E
    Nurs Times; 2006 Jun 20-26; 102(25):30-2. PubMed ID: 16826947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
    Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dental extractions in patients taking anticoagulants: is alteration of the anticoagulant regime necessary?].
    Madrid C
    Rev Med Suisse; 2005 May; 1(21):1418, 1421-2, 1424. PubMed ID: 15997980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.